Patents by Inventor Timothy Charles Gulbin

Timothy Charles Gulbin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10912719
    Abstract: This invention relates to an improved crystallization process of hydrogenated castor oil structurant which results in (i) a dispersion having a high concentration of the structurant, and (ii) a crystal habit/form that results in a higher yield stress in the final product, imparting high stability, for a given amount structurant. In addition, the resulting personal care product is consumer desired, as less structurant residue is observed on hair after the use of the personal care product.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: February 9, 2021
    Assignee: The Procter and Gamble Company
    Inventor: Timothy Charles Gulbin
  • Patent number: 10632200
    Abstract: A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: April 28, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Daniel Jerome White, Jr., Michael Selden Godlewski, Timothy Charles Gulbin, Graham John Myatt
  • Publication number: 20180303947
    Abstract: A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
    Type: Application
    Filed: June 28, 2018
    Publication date: October 25, 2018
    Inventors: Daniel Jerome White, Jr., Michael Selden Godlewski, Timothy Charles Gulbin, Graham John Myatt
  • Patent number: 10039835
    Abstract: A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: August 7, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Daniel Jerome White, Jr., Michael Selden Godlewski, Timothy Charles Gulbin, Graham John Myatt
  • Publication number: 20170021027
    Abstract: A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
    Type: Application
    Filed: October 10, 2016
    Publication date: January 26, 2017
    Inventors: Daniel Jerome White, JR., Michael Selden Godlewski, Timothy Charles Gulbin, Graham John Myatt
  • Patent number: 9486460
    Abstract: A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: November 8, 2016
    Assignee: The Procter & Gamble Company
    Inventors: Daniel Jerome White, Jr., Michael Selden Godlewski, Timothy Charles Gulbin, Graham John Myatt
  • Publication number: 20160106663
    Abstract: This invention relates to an improved crystallization process of hydrogenated castor oil structurant which results in (i) a dispersion having a high concentration of the structurant, and (ii) a crystal habit/form that results in a higher yield stress in the final product, imparting high stability, for a given amount structurant. In addition, the resulting personal care product is consumer desired, as less structurant residue is observed on hair after the use of the personal care product.
    Type: Application
    Filed: October 13, 2015
    Publication date: April 21, 2016
    Inventor: Timothy Charles Gulbin
  • Publication number: 20150306113
    Abstract: A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
    Type: Application
    Filed: April 29, 2015
    Publication date: October 29, 2015
    Inventors: Daniel Jerome White, Jr., Michael Selden Godlewski, Timothy Charles Gulbin, Graham John Myatt